TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway.

[1]  Jong-Seon Park,et al.  RGS2 is a negative regulator of STAT3-mediated Nox1 expression. , 2012, Cellular signalling.

[2]  T. V. van Berkel,et al.  Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoE , 2011, PloS one.

[3]  R. Molday,et al.  Lipid transport by mammalian ABC proteins. , 2011, Essays in biochemistry.

[4]  M. Gelb,et al.  Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages , 2011, The Journal of Immunology.

[5]  Hong Yang,et al.  Transcriptional Regulation of ATP-binding Cassette Transporter A1 Expression by a Novel Signaling Pathway* , 2011, The Journal of Biological Chemistry.

[6]  T. V. van Berkel,et al.  Enhanced Foam Cell Formation, Atherosclerotic Lesion Development, and Inflammation by Combined Deletion of ABCA1 and SR-BI in Bone Marrow–Derived Cells in LDL Receptor Knockout Mice on Western-Type Diet , 2010, Circulation research.

[7]  A. Eckhart,et al.  Regulation of GPCR signaling in hypertension. , 2010, Biochimica et biophysica acta.

[8]  C. Erridge,et al.  Toll-like receptor-dependent lipid body formation in macrophage foam cell formation , 2010, Current opinion in lipidology.

[9]  C. Monaco,et al.  The Expression and Functions of Toll-Like Receptors in Atherosclerosis , 2010, Mediators of inflammation.

[10]  X. Liu,et al.  Pathogen-Mediated Inflammatory Atherosclerosis Is Mediated in Part via Toll-Like Receptor 2-Induced Inflammatory Responses , 2010, Journal of Innate Immunity.

[11]  J. Herz,et al.  LRP1 Controls cPLA2 Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export , 2009, PloS one.

[12]  Joseph K. Pickrell,et al.  Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense , 2009, PLoS genetics.

[13]  S. Baek,et al.  A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. , 2008, Cellular signalling.

[14]  D. Strickland,et al.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. , 2008, Physiological reviews.

[15]  J. Sluijter,et al.  Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. , 2008, Atherosclerosis.

[16]  P. Tobias,et al.  Toll-like receptors in atherosclerosis. , 2007, Biochemical Society transactions.

[17]  Linda K. Curtiss,et al.  The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis. , 2007, Current drug targets.

[18]  M. Hayden,et al.  Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Schröder,et al.  Heme oxygenase-1 and cardiovascular disease. , 2006, Histology and histopathology.

[20]  G. Hansson,et al.  Inflammation and atherosclerosis. , 2006, Annual review of pathology.

[21]  Y. Yamauchi,et al.  Apolipoprotein A-I Activates Protein Kinase Cα Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein Assembly* , 2003, Journal of Biological Chemistry.

[22]  S. Ryu,et al.  Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway* , 2003, Journal of Biological Chemistry.

[23]  A. Tall,et al.  Regulation and mechanisms of macrophage cholesterol efflux. , 2002, The Journal of clinical investigation.

[24]  S. Wright,et al.  Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. , 2002, Journal of lipid research.

[25]  A. Remaley,et al.  Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells , 2002, Infection and Immunity.

[26]  R. F. Hoyt,et al.  The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Genest,et al.  Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. , 2001, Journal of lipid research.

[28]  R. Virmani,et al.  Pharmacologic Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis , 2012 .

[29]  Protein Kinase C- (cid:1) and Phospholipase D2 Pathway Regulates Foam Cell Formation via Regulator of G Protein Signaling 2 , 2022 .